about
On the generalizability of statistical expressions of health related quality of life instrument responsiveness: a data synthesis.Relationships between health literacy and heart failure knowledge, self-efficacy, and self-care adherence.Health literacy and self-care of patients with heart failure.Evaluation of chronic disease management on outcomes and cost of care for Medicaid beneficiaries.Health Literacy Influences Heart Failure Knowledge Attainment but Not Self-Efficacy for Self-Care or Adherence to Self-Care over Time.An instrument to assess subjective task value beliefs regarding the decision to pursue postgraduate training.Student pharmacists' attitudes toward complementary and alternative medicine.Practice Characteristics and Geographic Distribution of Clinical Pharmacist Practitioners in North Carolina.Perceived successes and challenges of clinical pharmacist practitioners in North Carolina.Theoretical exploration of Tennessee community pharmacists' perceptions regarding opioid pain reliever abuse communication.Correlates of Prescription Opioid Legitimacy Judgments Among Community Pharmacists.Predicting EQ-5D utility scores from the 25-item National Eye Institute Vision Function Questionnaire (NEI-VFQ 25) in patients with age-related macular degeneration.Factors associated with provision of addiction treatment information by community pharmacists.Provision of pain management by a pharmacist with prescribing authorityReimbursement for clinical services provided by pharmacists: what are we doing wrong?Patient Safety Forum: do state Medicaid preferred drug lists affect patient safety?Advanced-practice pharmacists: practice characteristics and reimbursement of pharmacists certified for collaborative clinical practice in New Mexico and North CarolinaEfficacy of guided imagery with relaxation for osteoarthritis symptoms and medication intakeMedicaid preferred drug lists: a success story?Experiences Applying Technology to Overcome Common Challenges in Pharmacy Practice-Based Research in the United States
P50
Q32109482-F97579CA-FA03-4BD2-963E-B0A99454BA64Q34364689-0F0249D2-7714-494E-893C-612209496290Q35100300-29098C68-1034-4FFC-BF69-D62CDB6A1833Q37061227-DA0E939B-8C55-4561-8E33-3C50675260F1Q37091114-A6CCA9B1-78EB-4B4B-8C11-59F28D70485CQ37595045-6C99D31A-C768-43E2-B838-9EEEA6D6D939Q39329671-8400A3CF-29EB-4007-BD41-D4CAD822F4FEQ40325845-D58DF3BB-1004-484E-92A1-E147052C4B9BQ43608285-175D2844-DD03-4787-887F-71AA16E754BFQ44079522-AB665C6A-C195-4CE5-921B-E1454D42829DQ44336474-BB1AADD5-B016-46E4-BBCD-94AEE900A6F9Q51818560-631CCDD7-74B1-4C94-93B8-1C0FB397AD84Q52306174-AB8A4765-0848-4B88-AD32-32D7AF01EEB4Q79451682-17020DE6-A0B6-4B36-9482-0A190D2DC603Q79451689-706BD70C-EAF1-447B-8BEE-0D9D0767E9C1Q81023839-A541DC6D-6DDE-4F04-9F39-4C17775D9717Q82773017-9BACC4E1-6461-4100-8278-5B9ED8F94888Q83145063-2B8A7B82-02B9-4100-B423-EBC926D0B44AQ84364037-7BAB9904-C539-49ED-9BB5-65CA237468B9Q96116788-90383D09-5991-423C-8977-734E0612E4BE
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Matthew M. Murawski
@ast
Matthew M. Murawski
@en
Matthew M. Murawski
@es
Matthew M. Murawski
@nl
Matthew M. Murawski
@sl
type
label
Matthew M. Murawski
@ast
Matthew M. Murawski
@en
Matthew M. Murawski
@es
Matthew M. Murawski
@nl
Matthew M. Murawski
@sl
prefLabel
Matthew M. Murawski
@ast
Matthew M. Murawski
@en
Matthew M. Murawski
@es
Matthew M. Murawski
@nl
Matthew M. Murawski
@sl
P106
P1153
35582987600
P31
P496
0000-0002-8612-0307